Portfolio Holdings Detail for ISIN IE00BYVJRR92
Stock Name / Fund iShares MSCI USA SRI UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker SUUS(GBX) LSE
ETF Ticker QDVR(EUR) F
ETF Ticker QDVR.DE(EUR) CXE
ETF Ticker SUAS.LS(USD) CXE
ETF Ticker SUASz(USD) CXE
ETF Ticker SUAU.AS(EUR) CXE
ETF Ticker SUAS(EUR) ETF Plus
ETF Ticker SUAU(EUR) Euronext Amsterdam
ETF Ticker SUUS.L(GBP) LSE

Holdings detail for VRTX

Stock Name	Vertex Pharmaceuticals Inc
Ticker	VRTX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US92532F1003
LEI	54930015RAQRRZ5ZGJ91

Show aggregate VRTX holdings

News associated with VRTX

Vertex Pharmaceuticals Secures Italian Reimbursement Agreement For Gene-Edited Therapy CASGEVY: (RTTNews) - Vertex Pharmaceuticals (VRTX), Thursday announced a reimbursement agreement with the Italian Medicines Agency that allows eligible transfusion-dependent beta thalassemia and severe sickle cell disease patients to access the CRISPR/Cas9 gene-edited therapy CASGEVY. - 2025-09-18 14:26:15
Why This Biotech Company Could Be a Growth Stock Powerhouse: Key PointsThis biotech is a leader in the treatment of cystic fibrosis, and that’s helped earnings explode higher over the years. - 2025-09-17 06:10:00
3 Absurdly Cheap Stocks to Buy for the Long Haul: Key PointsThese stocks are all down for the year, and things could get worse before they get better. - 2025-09-12 08:30:00
My 2 Favorite Stocks to Buy Right Now: Key PointsAmazon has multiple moats and paths to grow. - 2025-08-31 05:51:00
Capital Group Growth ETF Experiences Big Inflow: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Capital Group Growth ETF (Symbol: CGGR) where we have detected an approximate $162.3 million dollar inflow -- that's a 1.1% increase week over week i - 2025-08-29 11:52:16
Noteworthy ETF Inflows: CGBL, CGCP, CGCB, VRTX: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Capital Group Core Balanced ETF (Symbol: CGBL) where we have detected an approximate $272.2 million dollar inflow -- that's a 9.7% increase week over - 2025-08-15 11:50:39
2 Growth Stocks That Are No-Brainer Buys Right Now: Key PointsVertex Pharmaceuticals' recent dip presents an excellent buying opportunity, given its promising prospects. - 2025-08-15 09:30:00
Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Increased to Strong-Buy at Wall Street Zen: Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “strong-buy” rating in a report issued on Saturday. A number of other research firms have also recently weighed in on VRTX. Wells Fargo & Company raised shares of Vertex Pharmaceuticals from an “equal […] - 2025-08-11 02:58:48
The Smartest Growth Stocks to Buy With $1,000 Right Now: Key PointsVertex Pharmaceuticals' recent sell-off was overdone. - 2025-08-09 05:46:00
5 Top Stocks to Buy in August: Key PointsThe pullback in Netflix, Costco, and ASML is a buying opportunity. - 2025-08-08 07:45:00
Harbour Investments Inc. Acquires 68 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX): Harbour Investments Inc. increased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 19.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 410 shares of the pharmaceutical company’s stock after purchasing an additional 68 shares during the period. Harbour […] - 2025-08-07 05:54:57
Vertex Pharmaceuticals (NASDAQ:VRTX) Reaches New 52-Week Low on Analyst Downgrade: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report)’s share price hit a new 52-week low during trading on Wednesday after Canaccord Genuity Group lowered their price target on the stock from $424.00 to $411.00. Canaccord Genuity Group currently has a hold rating on the stock. Vertex Pharmaceuticals traded as low as $373.19 and last traded […] - 2025-08-07 05:08:45
Scotiabank Issues Pessimistic Forecast for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price: Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target lowered by Scotiabank from $442.00 to $438.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “sector perform” rating on the pharmaceutical company’s stock. Scotiabank’s target price suggests a potential upside of 13.57% from the company’s current price. Other research analysts […] - 2025-08-07 03:14:58
Vertex Pharmaceuticals (NASDAQ:VRTX) PT Set at $490.00 by Truist Financial: Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) received a $490.00 price objective from Truist Financial in a report issued on Tuesday, MarketBeat reports. The firm presently has a “buy” rating on the pharmaceutical company’s stock. Truist Financial’s price objective indicates a potential upside of 27.06% from the company’s previous close. A number of other equities […] - 2025-08-07 03:14:58
Vertex Pharmaceuticals (NASDAQ:VRTX) Shares Gap Down Following Analyst Downgrade: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) shares gapped down before the market opened on Tuesday after Canaccord Genuity Group lowered their price target on the stock from $424.00 to $411.00. The stock had previously closed at $472.27, but opened at $408.22. Canaccord Genuity Group currently has a hold rating on the stock. Vertex […] - 2025-08-07 02:42:43
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 14:19:48
Wednesday's ETF with Unusual Volume: LSGR: The Natixis Loomis Sayles Focused Growth ETF is seeing unusually high volume in afternoon trading Wednesday, with over 805,000 shares traded versus three month average volume of about 45,000. Shares of LSGR were up about 0.4% on the day. Components of that ETF with the highest - 2025-08-06 13:11:25
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 12:43:55
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 12:20:27
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 10:31:46
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 10:01:41
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 08:50:42
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 08:02:58
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 05:54:32
Royal Bank Of Canada Lowers Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $405.00: Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective trimmed by Royal Bank Of Canada from $430.00 to $405.00 in a research report sent to investors on Tuesday morning,Benzinga reports. The brokerage currently has a sector perform rating on the pharmaceutical company’s stock. A number of other equities research analysts have also issued reports […] - 2025-08-06 04:40:55
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut to $455.00 by Analysts at Stifel Nicolaus: Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective reduced by Stifel Nicolaus from $494.00 to $455.00 in a research note issued to investors on Tuesday morning,Benzinga reports. Stifel Nicolaus currently has a hold rating on the pharmaceutical company’s stock. VRTX has been the topic of several other reports. Scotiabank dropped their target price […] - 2025-08-06 04:40:55
HC Wainwright Has Lowered Expectations for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price: Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price decreased by HC Wainwright from $550.00 to $478.00 in a research report released on Tuesday,Benzinga reports. HC Wainwright currently has a buy rating on the pharmaceutical company’s stock. A number of other equities research analysts have also recently weighed in on VRTX. Leerink Partnrs cut […] - 2025-08-06 04:40:51
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 04:21:54
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 02:12:19
Stocks Pressured by Disappointing US Service Sector News: The S&P 500 Index ($SPX ) (SPY ) today is down -0.57%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.62%. September E-mini S&P futures (ESU25 ) are down -0.55%, and September E-mini Nasdaq futures... - 2025-08-05 19:47:15

iShares MSCI USA SRI UCITS ETF USD (Acc) VRTX holdings

Date	Number of VRTX Shares Held	Base Market Value of VRTX Shares	Local Market Value of VRTX Shares	Change in VRTX Shares Held	Change in VRTX Base Value	Current Price per VRTX Share Held	Previous Price per VRTX Share Held
2025-10-01 (Wednesday)	74,421	USD 30,081,712	USD 30,081,712
2025-09-30 (Tuesday)	73,921	USD 28,950,420	USD 28,950,420	0	USD -271,291	USD 391.64	USD 395.31
2025-09-29 (Monday)	73,921	USD 29,221,711	USD 29,221,711	0	USD 707,794	USD 395.31	USD 385.735
2025-09-26 (Friday)	73,921	USD 28,513,917	USD 28,513,917	-108	USD 244,463	USD 385.735	USD 381.87
2025-09-25 (Thursday)	74,029	USD 28,269,454	USD 28,269,454	0	USD 388,652	USD 381.87	USD 376.62
2025-09-24 (Wednesday)	74,029	USD 27,880,802	USD 27,880,802	-117	USD -821,856	USD 376.62	USD 387.11
2025-09-18 (Thursday)	74,146	USD 28,702,658	USD 28,702,658	-108	USD -44,778	USD 387.11	USD 387.15
2025-09-17 (Wednesday)	74,254	USD 28,747,436	USD 28,747,436	0	USD -312,609	USD 387.15	USD 391.36
2025-09-16 (Tuesday)	74,254	USD 29,060,045	USD 29,060,045	0	USD -137,370	USD 391.36	USD 393.21
2025-09-15 (Monday)	74,254	USD 29,197,415	USD 29,197,415	0	USD -98,016	USD 393.21	USD 394.53

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VRTX by Blackrock for IE00BYVJRR92

Show aggregate share trades of VRTX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-26 SELL -108 385.735* 456.58 Profit of 49,310 on sale
2025-09-24 SELL -117 376.620* 457.85 Profit of 53,569 on sale
2025-09-18 SELL -108 387.110* 458.44 Profit of 49,512 on sale
2025-09-10 BUY 102 388.550* 461.94
2025-09-08 SELL -534 395.250* 463.12 Profit of 247,306 on sale
2025-08-27 SELL -1,225 389.080* 465.80 Profit of 570,603 on sale
2025-08-06 SELL -440 385.650* 467.97 Profit of 205,905 on sale
2025-08-04 SELL -110 472.270* 468.83 Profit of 51,571 on sale
2025-07-31 SELL -110 456.870* 469.01 Profit of 51,591 on sale
2025-07-30 SELL -715 469.160* 469.01 Profit of 335,343 on sale
2025-07-29 SELL -385 468.410* 469.02 Profit of 180,571 on sale
2025-07-28 SELL -495 460.830* 469.10 Profit of 232,205 on sale
2025-07-18 BUY 52 459.810* 469.31
2025-07-17 BUY 584 463.270* 469.37
2025-07-16 SELL -432 469.550* 469.37 Profit of 202,767 on sale
2025-07-15 SELL -324 464.200* 469.42 Profit of 152,094 on sale
2025-07-11 BUY 216 468.850* 469.40
2025-07-10 BUY 324 479.530* 469.29
2025-07-09 SELL -270 478.965* 469.18 Profit of 126,678 on sale
2025-07-08 SELL -1,472 466.360* 469.21 Profit of 690,677 on sale
2025-06-30 BUY 472 445.200* 469.99
2025-06-27 SELL -702 441.300* 470.34 Profit of 330,182 on sale
2025-06-26 SELL -54 443.400* 470.68 Profit of 25,417 on sale
2025-06-24 SELL -126 450.270* 471.25 Profit of 59,378 on sale
2025-06-20 SELL -1,104 440.870* 472.00 Profit of 521,093 on sale
2025-06-17 SELL -2,322 441.990* 473.05 Profit of 1,098,418 on sale
2025-06-13 SELL -270 455.450* 473.60 Profit of 127,872 on sale
2025-06-12 BUY 260 460.060* 473.79
2025-06-09 SELL -594 446.150* 474.84 Profit of 282,054 on sale
2025-06-06 SELL -156 450.500* 475.20 Profit of 74,132 on sale
2025-06-04 SELL -1,026 445.850* 476.14 Profit of 488,516 on sale
2025-06-03 SELL -270 446.480* 476.60 Profit of 128,682 on sale
2025-05-30 BUY 2,511 442.050* 477.66
2025-05-27 SELL -52 446.000* 479.27 Profit of 24,922 on sale
2025-05-23 SELL -676 436.000* 480.78 Profit of 325,010 on sale
2025-05-21 SELL -260 435.320* 482.46 Profit of 125,440 on sale
2025-05-19 SELL -102 440.660* 483.92 Profit of 49,359 on sale
2025-05-16 BUY 620 438.650* 484.79
2025-05-15 SELL -104 434.380* 485.77 Profit of 50,521 on sale
2025-05-14 SELL -104 421.160* 487.07 Profit of 50,655 on sale
2025-05-13 SELL -52 432.000* 488.19 Profit of 25,386 on sale
2025-05-12 SELL -156 439.370* 489.21 Profit of 76,316 on sale
2025-05-09 SELL -52 424.990* 490.57 Profit of 25,510 on sale
2025-05-08 SELL -624 429.600* 491.90 Profit of 306,945 on sale
2025-05-01 SELL -2 498.860* 493.72 Profit of 987 on sale
2025-04-30 SELL -416 509.500* 493.32 Profit of 205,222 on sale
2025-04-28 SELL -2,028 496.490* 492.97 Profit of 999,743 on sale
2025-04-25 BUY 260 493.840* 492.95
2025-04-23 SELL -104 492.420* 492.97 Profit of 51,269 on sale
2025-04-17 BUY 52 489.100* 493.80
2025-04-14 SELL -104 495.830* 493.78 Profit of 51,353 on sale
2025-04-11 BUY 371 484.220* 494.13
2025-04-10 SELL -52 475.490* 494.85 Profit of 25,732 on sale
2025-04-09 BUY 156 482.300* 495.35
2025-04-08 SELL -150 472.370* 496.31 Profit of 74,446 on sale
2025-04-07 SELL -624 474.560* 497.25 Profit of 310,285 on sale
2025-04-04 SELL -520 474.620* 498.28 Profit of 259,106 on sale
2025-04-02 SELL -932 483.490* 498.98 Profit of 465,053 on sale
2025-03-31 BUY 284 484.820* 500.48
2025-03-28 BUY 104 492.690* 500.91
2025-03-27 SELL -22 502.550* 500.82 Profit of 11,018 on sale
2025-03-26 BUY 156 500.280* 500.85
2025-03-25 BUY 260 509.040* 500.30
2025-03-21 SELL -260 503.200* 499.20 Profit of 129,792 on sale
2025-03-20 SELL -52 510.180* 498.29 Profit of 25,911 on sale
2025-03-19 SELL -260 512.520* 496.99 Profit of 129,218 on sale
2025-03-18 SELL -156 512.230* 495.47 Profit of 77,293 on sale
2025-03-14 SELL -260 504.770* 492.02 Profit of 127,925 on sale
2025-03-13 SELL -1,196 502.920* 490.46 Profit of 586,592 on sale
2025-03-12 SELL -52 495.420* 489.64 Profit of 25,461 on sale
2025-03-11 SELL -310 488.340* 489.89 Profit of 151,867 on sale
2025-03-07 SELL -1,404 488.290* 487.06 Profit of 683,828 on sale
2025-03-05 SELL -156 491.640* 484.76 Profit of 75,623 on sale
2025-03-03 BUY 520 483.310* 0.00
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-26	SELL	-108	385.735*	456.58 Profit of 49,310 on sale
2025-09-24	SELL	-117	376.620*	457.85 Profit of 53,569 on sale
2025-09-18	SELL	-108	387.110*	458.44 Profit of 49,512 on sale
2025-09-10	BUY	102	388.550*	461.94
2025-09-08	SELL	-534	395.250*	463.12 Profit of 247,306 on sale
2025-08-27	SELL	-1,225	389.080*	465.80 Profit of 570,603 on sale
2025-08-06	SELL	-440	385.650*	467.97 Profit of 205,905 on sale
2025-08-04	SELL	-110	472.270*	468.83 Profit of 51,571 on sale
2025-07-31	SELL	-110	456.870*	469.01 Profit of 51,591 on sale
2025-07-30	SELL	-715	469.160*	469.01 Profit of 335,343 on sale
2025-07-29	SELL	-385	468.410*	469.02 Profit of 180,571 on sale
2025-07-28	SELL	-495	460.830*	469.10 Profit of 232,205 on sale
2025-07-18	BUY	52	459.810*	469.31
2025-07-17	BUY	584	463.270*	469.37
2025-07-16	SELL	-432	469.550*	469.37 Profit of 202,767 on sale
2025-07-15	SELL	-324	464.200*	469.42 Profit of 152,094 on sale
2025-07-11	BUY	216	468.850*	469.40
2025-07-10	BUY	324	479.530*	469.29
2025-07-09	SELL	-270	478.965*	469.18 Profit of 126,678 on sale
2025-07-08	SELL	-1,472	466.360*	469.21 Profit of 690,677 on sale
2025-06-30	BUY	472	445.200*	469.99
2025-06-27	SELL	-702	441.300*	470.34 Profit of 330,182 on sale
2025-06-26	SELL	-54	443.400*	470.68 Profit of 25,417 on sale
2025-06-24	SELL	-126	450.270*	471.25 Profit of 59,378 on sale
2025-06-20	SELL	-1,104	440.870*	472.00 Profit of 521,093 on sale
2025-06-17	SELL	-2,322	441.990*	473.05 Profit of 1,098,418 on sale
2025-06-13	SELL	-270	455.450*	473.60 Profit of 127,872 on sale
2025-06-12	BUY	260	460.060*	473.79
2025-06-09	SELL	-594	446.150*	474.84 Profit of 282,054 on sale
2025-06-06	SELL	-156	450.500*	475.20 Profit of 74,132 on sale
2025-06-04	SELL	-1,026	445.850*	476.14 Profit of 488,516 on sale
2025-06-03	SELL	-270	446.480*	476.60 Profit of 128,682 on sale
2025-05-30	BUY	2,511	442.050*	477.66
2025-05-27	SELL	-52	446.000*	479.27 Profit of 24,922 on sale
2025-05-23	SELL	-676	436.000*	480.78 Profit of 325,010 on sale
2025-05-21	SELL	-260	435.320*	482.46 Profit of 125,440 on sale
2025-05-19	SELL	-102	440.660*	483.92 Profit of 49,359 on sale
2025-05-16	BUY	620	438.650*	484.79
2025-05-15	SELL	-104	434.380*	485.77 Profit of 50,521 on sale
2025-05-14	SELL	-104	421.160*	487.07 Profit of 50,655 on sale
2025-05-13	SELL	-52	432.000*	488.19 Profit of 25,386 on sale
2025-05-12	SELL	-156	439.370*	489.21 Profit of 76,316 on sale
2025-05-09	SELL	-52	424.990*	490.57 Profit of 25,510 on sale
2025-05-08	SELL	-624	429.600*	491.90 Profit of 306,945 on sale
2025-05-01	SELL	-2	498.860*	493.72 Profit of 987 on sale
2025-04-30	SELL	-416	509.500*	493.32 Profit of 205,222 on sale
2025-04-28	SELL	-2,028	496.490*	492.97 Profit of 999,743 on sale
2025-04-25	BUY	260	493.840*	492.95
2025-04-23	SELL	-104	492.420*	492.97 Profit of 51,269 on sale
2025-04-17	BUY	52	489.100*	493.80
2025-04-14	SELL	-104	495.830*	493.78 Profit of 51,353 on sale
2025-04-11	BUY	371	484.220*	494.13
2025-04-10	SELL	-52	475.490*	494.85 Profit of 25,732 on sale
2025-04-09	BUY	156	482.300*	495.35
2025-04-08	SELL	-150	472.370*	496.31 Profit of 74,446 on sale
2025-04-07	SELL	-624	474.560*	497.25 Profit of 310,285 on sale
2025-04-04	SELL	-520	474.620*	498.28 Profit of 259,106 on sale
2025-04-02	SELL	-932	483.490*	498.98 Profit of 465,053 on sale
2025-03-31	BUY	284	484.820*	500.48
2025-03-28	BUY	104	492.690*	500.91
2025-03-27	SELL	-22	502.550*	500.82 Profit of 11,018 on sale
2025-03-26	BUY	156	500.280*	500.85
2025-03-25	BUY	260	509.040*	500.30
2025-03-21	SELL	-260	503.200*	499.20 Profit of 129,792 on sale
2025-03-20	SELL	-52	510.180*	498.29 Profit of 25,911 on sale
2025-03-19	SELL	-260	512.520*	496.99 Profit of 129,218 on sale
2025-03-18	SELL	-156	512.230*	495.47 Profit of 77,293 on sale
2025-03-14	SELL	-260	504.770*	492.02 Profit of 127,925 on sale
2025-03-13	SELL	-1,196	502.920*	490.46 Profit of 586,592 on sale
2025-03-12	SELL	-52	495.420*	489.64 Profit of 25,461 on sale
2025-03-11	SELL	-310	488.340*	489.89 Profit of 151,867 on sale
2025-03-07	SELL	-1,404	488.290*	487.06 Profit of 683,828 on sale
2025-03-05	SELL	-156	491.640*	484.76 Profit of 75,623 on sale
2025-03-03	BUY	520	483.310*	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VRTX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	253,408	88	822,586	30.8%
2025-09-18	262,277	45	831,580	31.5%
2025-09-17	158,866	890	1,012,591	15.7%
2025-09-16	233,484	702	769,823	30.3%
2025-09-15	385,606	97	605,410	63.7%
2025-09-12	198,306	54	325,925	60.8%
2025-09-11	217,651	160	455,823	47.7%
2025-09-10	441,550	65	640,409	68.9%
2025-09-09	216,563	711	395,377	54.8%
2025-09-08	285,371	226	594,102	48.0%
2025-09-05	209,916	9	413,663	50.7%
2025-09-04	236,777	2,164	365,713	64.7%
2025-09-03	212,085	7	457,751	46.3%
2025-09-02	318,587	425	689,371	46.2%
2025-08-29	136,055	7	344,317	39.5%
2025-08-28	189,040	229	437,536	43.2%
2025-08-27	204,685	373	919,772	22.3%
2025-08-26	195,209	380	616,641	31.7%
2025-08-25	205,216	929	405,536	50.6%
2025-08-22	187,538	366	477,729	39.3%
2025-08-21	357,256	454	694,264	51.5%
2025-08-20	304,195	196	620,591	49.0%
2025-08-19	193,253	370	598,168	32.3%
2025-08-18	197,043	357	581,908	33.9%
2025-08-15	213,454	413	509,240	41.9%
2025-08-14	299,335	536	798,768	37.5%
2025-08-13	342,897	6,746	694,047	49.4%
2025-08-12	361,071	536	689,425	52.4%
2025-08-11	478,787	177	1,141,772	41.9%
2025-08-08	382,688	480	1,467,480	26.1%
2025-08-07	802,775	500	1,747,924	45.9%
2025-08-06	1,070,384	29,978	2,256,489	47.4%
2025-08-05	2,087,742	66,027	4,981,303	41.9%
2025-08-04	329,631	253	766,131	43.0%
2025-08-01	290,545	239	729,079	39.9%
2025-07-31	227,826	151	513,336	44.4%
2025-07-30	134,793	234	361,144	37.3%
2025-07-29	124,474	331	372,446	33.4%
2025-07-28	125,989	264	519,868	24.2%
2025-07-25	136,582	104	432,897	31.6%
2025-07-24	144,869	169	321,736	45.0%
2025-07-23	182,307	1,460	370,788	49.2%
2025-07-22	193,759	402	450,155	43.0%
2025-07-21	174,382	14,621	318,671	54.7%
2025-07-18	203,357	10,091	296,802	68.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares MSCI USA SRI UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	SUUS(GBX) LSE
ETF Ticker	QDVR(EUR) F
ETF Ticker	QDVR.DE(EUR) CXE
ETF Ticker	SUAS.LS(USD) CXE
ETF Ticker	SUASz(USD) CXE
ETF Ticker	SUAU.AS(EUR) CXE
ETF Ticker	SUAS(EUR) ETF Plus
ETF Ticker	SUAU(EUR) Euronext Amsterdam
ETF Ticker	SUUS.L(GBP) LSE